Medtech stories we missed this week: May 25, 2018

From Mauna Kea receiving FDA clearance to Medacta getting clearance for its pedicle screw placement guide, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Mauna Kea wins FDA nod for neurosurgery indication Mauna Kea announced in a May 24 press releasethat it has received FDA 510(k) clearance for

8 companies commercializing transcatheter mitral valve replacements

Transcatheter mitral valve replacement is a new frontier in the cardio device field, with big legacy medical device companies including Edwards Lifesciences, Medtronic and Abbott spending hundreds of millions of dollars on companies in the space. Much different from transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR) has been mostly experimental. TMVR is used

Pages: 1 2 3 4 5 6 7 8 9

Minnesota’s Medical Alley has a big presence at EuroPCR

The Medical Alley Association in Minnesota is touting the major presence that companies and organizations from the state will have at this year’s EuroPCR, which is being held this week in Paris. The event — the European Association of Percutaneous Cardiovascular Interventions’ annual meeting — is May 22–25 at the Palais des Congrès and is expected to

This procedure could alleviate sinus pain and inflammation without surgery

A researcher at The Ohio State University is conducting a clinical trial to test a new, non-invasive approach to sinus procedures that helps alleviate chronic nasal symptoms. Dr. Brad Otto, an ENT-Otolaryngologist at The Ohio State University’s Wexner Medical Center, is conducting the clinical trial to see how the non-invasive procedure can give surgery-like results.

Peelable tubing technology could transform miniaturized catheters

Here’s how peelable tubing technology is leading to advances in catheterization. Joe Rowan, Junkosha The future of the medical tubing sector is an interesting one, not least because there are a variety of pressures on organizations within this space to provide cost-effective, highest quality products in shorter timescales. This is mainly driven by the global healthcare

Medtech stories we missed this week: May 11, 2018

From ReShape submitting an approval application to Health Canada to Conavi receiving FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. ReShape submits for Health Canada approval of ReShape balloon ReShape announced in a May 10 press releasethat it has submitted an application to the Medical Devices Bureau of

Alcon launches project to reduce cataract blindness

Alcon, a division of Novartis, launched its Alcon Cares Project 100 to take steps in reducing cataract blindness globally. The company also plans to donate 100 reprocessed Infiniti units to eligible clinics in Asia, Central and South America and Africa over the next three years. Alcon aims to reduce cataract blindness by providing equipment to

All heart: A Google executive’s real-world experience with medtech

After hearing the story of her 10 cardiac surgeries and seven pacemakers, you could be forgiven for thinking that Heidi Dohse has a weak heart. But the Google executive, endurance cyclist and, now, inspirational speaker she may have a stronger heart than most people on the planet. Dohse, a senior program manager at Google and

This research advance could boost blood vessel growth and improve endurance

Massachusetts Institute of Technology researchers think they’ve developed a way to promote new blood vessel growth to reverse age-related endurance loss that comes with blood vessels losing their capacity to deliver oxygen and nutrients to muscle tissue. The MIT researchers developed a compound that reactivates longevity-linked proteins also promotes the growth of blood vessels and muscle

The best medtech funding option you’ve never heard of

Regulation A+ (Reg A+) is a funding option that feels tailor-made for high impact technologies like medtech. Never heard of it? That’s because it didn’t exist until 2015, when the Obama administration passed the JOBS Act. Before then, private companies could only seek backing from the wealthiest 2% of Americans — accredited investors. The new

For this Abbott executive, solving problems isn’t enough: ‘We need to add value’

As payers and providers across healthcare shift their focus to value-based care, leaders in the medical device industry are racing to keep up. Michael Pederson, SVP of cardiac arrhythmias and heart failure at Abbott, told MassDevice.com why simply solving problems with new technology isn’t enough anymore. What was your path like from electrical engineering to

Physio-Control launches chest compression system

Physio-Control has launched its Lucas 3 Chest Compression System, version 3.1. The new versos gives new capabilities for tailored device functionality while supporting wireless reporting and device status notification sent through email. The Lucas 3.1 system features setup options for compression rate/depth, pauses, alerts, timer and ventilation for local emergency care protocol. It also has

Medtech stories we missed this week: April 27, 2018

From DuPuy Synthes’s spinal implant launch to Lumendi’s FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. DePuy Synthes launches spinal implants DePuy Synthes announced in an April 26 press release that it has launched its Proti 360º integrated titanium family of interbody devices that are designed

The 10 hottest medtech startups of 2018

There’s a complaint sometimes that innovation is too incremental in the medical device industry. But don’t tell that to the people running the 10 companies included in Medical Design & Outsourcing and MassDevice’s list of the hottest medtech startups of 2018. Our editors came up with a list of 20 interesting young companies. We then

Pages: 1 2 3 4 5 6 7 8 9 10 11

3D printing can reduce heart valve leaks: Here’s how

Doctors can use 3D printing and computer modeling to predict paravavular leak (PVL) in patients who are undergoing transcatheter aortic valve replacement (TAVR), according to new research from the University of Minnesota. One of the common risks associated with TAVR is valves not fitting which can cause PVL. A recent study conducted by cardiovascular fellow